SCHEMBL8235262

SCHEMBL8235262

C=C(C)c1ccc(C)c(-c2ccc(NCCCC)cc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
MAPK14 Q16539 8/20 0.40
LMNA P02545 2/20 0.39
SCN5A Q14524 2/20 0.39
CYP1A2 P05177 1/20 0.39
MAOA P21397 1/20 0.39
CNR1 P21554 1/20 0.39
DRD4 P21917 1/20 0.39
ACHE P22303 1/20 0.39
HRH2 P25021 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
MAPK1 P28482 1/20 0.39
NTSR1 P30989 1/20 0.39
HRH1 P35367 1/20 0.39
DRD3 P35462 1/20 0.39
SCN1A P35498 1/20 0.39
HTR2B P41595 1/20 0.39
SCN7A Q01118 1/20 0.39
SLC6A3 Q01959 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5030644 0.82 SCN5A (0.50) ALDH1A1MAPK14LMNASCN5ACYP1A2
SCHEMBL27417295 0.75 ALDH1A1 (0.47) ALDH1A1LMNASCN5ACYP1A2MAOA
SCHEMBL30800856 0.71 MAPT (0.46) ALDH1A1LMNASCN5ACYP1A2MAOA
SCHEMBL19035328 0.70 ALDH1A1 (0.41) ALDH1A1LMNASCN5ACYP1A2MAOA
SCHEMBL24328007 0.70 ALDH1A1 (0.49) ALDH1A1ABL1PLK1
SCHEMBL5030834 0.69 RAB9A (0.40) ALDH1A1LMNACYP1A2MAPK1KDM4E
SCHEMBL8233425 0.69 RARB (0.46) ALDH1A1LMNASCN5ACYP1A2MAOA
SCHEMBL181559 0.69 MAPT (0.52) ALDH1A1LMNASCN5ACYP1A2MAOA
SCHEMBL11798071 0.69 ALDH1A1 (0.54) ALDH1A1CYP1A2HDAC1HDAC8HDAC6
SCHEMBL10997394 0.69 LMNA (0.56) LMNASCN5ACYP1A2MAOACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007087442-A2 SUBSTITUTED BIARYL COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2007-08-02 WO disclosed